Search

The detailed estimation of XRD microstructural elements such as Scherrer (Sch.) size of crystallite, Williamson-Hall (WH) size of crystallite and microscopic strain was highlighted via a novel modelling approach which relies on the broadening parameters named as the experimental broadening, crystallite size broadening and strain broadening. This approach was applied on the strain aged 6063 Al-alloys which are considered one of the backbones in the applications related to energy industries and manufacturers like vehicles and planes due to their light densities, availabilities and facile in fabrication. Three divergent aged specimens deformed at different percentages 0%, 5% and 30% respectively. The XRD results through modelling approach was comparable to the Rietveld MAUD (RM) refinement approach, which was served as a comparing and confirming tool. The estimated microstructural factors as a variation of the ageing time by the broadening analysis using the novel method were in a good agreement with Rietveld analysis using MAUD software program. The behaviour of both size of crystallite and micro strain exhibits two opposite pathways via the ageing time variation including small noises until to reach 400 hours at which the mean values of both of them nearly being constant for all distorted and non-distorted specimens. [ABSTRACT FROM AUTHOR]

Background: Malignant pleural effusion is a common problem in patients with solid tumours. It has a significant impact on quality of life, and, hence, there is a substantial need to investigate new agents to treat it. Patients and methods: This is a prospective randomised controlled study, including patients with symptomatic recurrent malignant pleural effusion of different primaries. Patients were randomised into two groups: the first group received five ampoules of mistletoe preparation with defined lectin content (Viscum Fraxini-2, ATOS Pharma) diluted in 10 cc glucose 5% solution. Re-instillation was repeated every week until complete dryness of the pleural fluid was achieved (the maximum duration of the therapy was eight weeks). The second group received 60 units of bleomycin once intrapleurally. Aims: The primary aim of this paper was to evaluate the efficacy of mistletoe preparation as a palliative treatment for malignant pleural effusions in comparison with bleomycin. The secondary aim was to evaluate the tolerability of the mistletoe preparation. Results: A total of 23 patients were included and followed up during the study from December 2007 to January 2012: 13 patients received mistletoe preparation, and ten patients received bleomycin. Overall clinical response was reported in 61.5% of the mistletoe preparation arm versus 30% in bleomycin arm (p = 0.2138), 95% CI = (-0.1203, 0.6325). The toxicity of both arms was mild and manageable; the mistletoe preparation arm included fever, chills, headache, malaise, and, in two cases, allergic reaction, which was controlled by discontinuation of the drug and steroid injection. Conclusion: Mistletoe preparation is an efficient and well tolerated sclerosant agent which needs further investigation. [ABSTRACT FROM AUTHOR]